Fig. 1From: Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effectsKPS scores of both groups before and after treatment. There is no difference in KPS scores between the two groups before treatment, but after treatment, the scores are improved and those of group B are higher than those of group A (p<0.05). Note: *p<0.05Back to article page